Clinical Trials Logo

Lung Disease, Obstructive clinical trials

View clinical trials related to Lung Disease, Obstructive.

Filter by:
  • None
  • Page 1

NCT ID: NCT02592122 Recruiting - Clinical trials for Lung Disease,Obstructive

Airway Responsiveness in Patients With AECOPD Mechanical Ventilation by Inspiratory and Bronchial Dilation Testchronic Obstructive Pulmonary Disease

Start date: October 2013
Phase: N/A
Study type: Interventional

In the patients with COPD mechanical ventilation, the bronchial dilatation is very common. However, the evaluation of the efficacy of the medical examination and other subjective indicators, such as doctors, depends on the doctor's experience; at present, there is no objective evaluation index. For patients with mechanical ventilation, the risk of cross infection can not only increase the risk of cross infection, but also increase the workload of clinical doctors and nurses. Therefore, this study proposes an objective evaluation method to evaluate the response of COPD patients to bronchial dilation. The hypothesis of this study can be used to guide the clinical medication through the test of the bronchus. If the patients with bronchial dilation test positive were used in the test, the patients were not used. In this evaluation method, the changes of airway resistance were measured by the accurate measurement of the patients with inhaled bronchial dilatation.

NCT ID: NCT01365702 Recruiting - Tuberculosis Clinical Trials

Tiotropium in Patients With Tuberculosis (TB) Destroyed Lung

Start date: June 2011
Phase: N/A
Study type: Observational

The aim of this study to evaluate clinical efficacy of tiotropium in patients with airflow obstruction due to Tuberculosis (TB) destroyed lung.

NCT ID: NCT00934713 Completed - Clinical trials for Signs and Symptoms, Respiratory

The Effect of Montelukast Treatment in Wheezy Infants

Montelukast
Start date: September 2004
Phase: Phase 4
Study type: Interventional

The study is designed to evaluate the efficacy of montelukast on symptom-free days in unselected group of very young children with wheeze and recurrent asthma like symptoms. The secondary aim was to evaluate the effect of montelukast on lung function, airway responsiveness, airway inflammation and use of rescue medication.